Unlocking Genomic Insights: A New Era for Baltic Science

The Baltic region’s scientific community is experiencing a significant boost in its research capabilities, thanks to a strategic partnership between the High-Performance Computing Center (RTU HPC) in Latvia and Gcore, a global cloud services provider. This collaboration is accelerating the growth of Machine Intelligence (MI) projects, particularly in the critical field of genome analysis.

RTU HPC, the largest supercomputing resource provider in Latvia, is working closely with the Latvian Biomedical Research and Study center (BMC), a leader in molecular biology and biomedical research. BMC’s research focuses on analyzing the genomes of thousands of individuals as part of various European initiatives, aiming to understand the genetic basis of health and disease.

The Challenge: Speed and Security in Genome Processing

Genome studies are fundamental to understanding human health and the origins of disease. However, the sheer volume of data involved demands exceptionally powerful computing resources. RTU HPC is spearheading a transition from traditional scientific computing to MI-driven innovation to address this challenge.

A key objective of the collaboration between RTU HPC and BMC is to expedite the processing of vast genomic datasets using MI, while maintaining strict control over data security and sovereignty. This is particularly critically important given increasing concerns about data privacy and the limitations of relying solely on foreign service providers.

Basically,we wanted to speed up the identification of variants,the computing process that identifies genetic variations.
Edgar Liepa, Bioinformatician at BMC

overcoming Computational Bottlenecks with GPUaaS

Traditional CPU-based computing often struggles to efficiently handle large-scale genome sequencing and analysis, leading to prolonged processing times. RTU HPC faced several critical challenges:

1. The imperative for faster genome sequencing to accelerate biomedical studies.
2. The need for enhanced computing power to effectively analyze massive datasets.
3. Difficulties in procuring high-performance GPU hardware within a reasonable timeframe.
4. The requirement for scalable computing solutions that minimize upfront capital expenditure.

To address these challenges, RTU HPC strategically partnered with Gcore, leveraging their GPU as a service (GPUaaS) offering. This approach provides immediate access to high-performance computing resources without the delays associated with hardware procurement.

Gcore’s GPUaaS: A game Changer for Genomic Research

Gcore’s GPUaaS provides RTU researchers with access to cutting-edge NVIDIA GPUs, including the H100, specifically designed for demanding MI workloads. These resources are hosted within Gcore’s European cloud infrastructure, ensuring data security and compliance with regional regulations.

The benefits of GPUaaS extend beyond raw processing power. It also offers scalability, allowing researchers to adjust their computing resources as needed, and eliminates the need for large initial investments in hardware. This agility is crucial in the rapidly evolving field of genomics.

Although no real human genome data was used in this test, the human reference genome data was publicly available, we wanted to make sure that the data will be processed securely and stored accordingly.Second, the GCORE platform provided us with immediate access to the required cloud infrastructure for the test – including GPU, data storage and fast data transmission mechanism.
Andris Locāns, RTU HPC Manager

The Future of Genomic Research in the Baltics

The collaboration between RTU HPC and Gcore represents a significant step forward for genomic research in the Baltic region. By providing access to advanced computing resources and prioritizing data security, this partnership is empowering researchers to unlock new insights into human health and disease. As the demand for MI-driven solutions continues to grow, GPUaaS is poised to play an increasingly vital role in accelerating scientific finding.

According to a recent report by Grand View Research, the global genomics market is projected to reach $62.9 billion by 2030, driven by advancements in sequencing technologies and the growing adoption of personalized medicine.Initiatives like the RTU HPC and Gcore partnership are crucial for ensuring that the Baltic region remains at the forefront of this rapidly evolving field.

The Power of Cloud Computing in Genome Sequencing

The field of genomics is undergoing a seismic shift, driven by the increasing availability and affordability of cloud-based high-performance computing (HPC) solutions. Researchers are now leveraging the power of cloud infrastructure, particularly Graphics Processing Units (GPUs), to dramatically accelerate genome analysis, reduce costs, and gain deeper insights into complex biological systems. This transformation is exemplified by a recent collaboration between Riga Technical University’s High-Performance Computing (RTU HPC) center, the Biomedical Center (BMC), and Gcore, a leading cloud services provider.

Overcoming Infrastructure Barriers with Cloud-Based GPUs

Traditionally, genomic research has been hampered by the significant investment and logistical challenges associated with acquiring and maintaining powerful computing infrastructure. The lengthy procurement processes and the need for specialized expertise frequently enough created bottlenecks, slowing down the pace of discovery. Though, cloud computing offers a compelling choice, providing researchers with on-demand access to cutting-edge hardware without the upfront costs or ongoing maintenance burdens.

The collaboration between RTU HPC, BMC, and Gcore highlights the tangible benefits of this approach. By partnering with Gcore, the research team gained:

• Instant Access to High-Performance gpus: Eliminating the delays associated with traditional hardware procurement.
• Scalability and Cost-Effectiveness: Utilizing a flexible “pay-as-you-go” model to optimize resource allocation based on specific research needs. this is particularly crucial in genomics, where data volumes can vary significantly. According to a recent report by GenomeWeb, cloud-based genomics solutions can reduce computing costs by up to 40%.
• Enhanced Data security and Control: Ensuring the secure processing and storage of sensitive genomic data.
• optimized performance through GPU Comparison: Conducting comparative evaluations of various GPU configurations (V100, A100, L40S, H100) using Nvidia Clara Parabricks software to identify the most efficient solutions for genome analysis.

Real-World Impact: Accelerating Research Timelines

The impact of this collaboration is best illustrated by the dramatic reduction in processing times. As E. Liepa, a researcher at BMC, noted:

Using Gcore, we had almost immediate access to computing. It would take half a year to implement this solution internally. This choice entirely changed the pace of our work, allowing the results to get much faster.
E. liepa, BMC Researcher

This sentiment underscores the transformative potential of cloud computing in accelerating scientific discovery. the ability to rapidly access and deploy powerful computing resources empowers researchers to tackle complex problems with unprecedented speed and efficiency.

Benchmarking Performance: CPU vs. GPU

A key aspect of the collaboration involved rigorous performance testing to compare the efficiency of CPUs and GPUs in genome sequencing. The results were striking:

Genome sequencing time,which previously took over 650 minutes using CPUs,was reduced to less than 30 minutes with GPU-accelerated processing. this represents a significant enhancement in processing speed, enabling researchers to analyze larger datasets and generate results much faster.

Furthermore, experiments with different GPU configurations revealed that simply increasing the number of GPUs does not always translate to faster processing. Careful optimization and selection of the appropriate GPU architecture are crucial for maximizing performance.

Unlocking New Possibilities with Advanced GPUs

The collaboration with Gcore has also opened doors for further exploration of GPU applications in genome analysis, including discussions with Nvidia regarding the use of their advanced GPU technologies.

Gcore’s Nvidia H100 GPUs offer exceptional computing power, specifically designed to meet the demands of high-performance computing applications like genomics. As Edgar Liepa explained:

It was important for us to see how fast the H100 works at the inferencing. We also did not adjust the model, but we used a solution developed by Nvidia, which was already well tailored to our goals and tasks.
Edgar Liepa, RTU HPC

Key Benefits of the Collaboration

The partnership between RTU HPC, BMC, and Gcore has yielded significant benefits for the Genome Research Program, including:

1. Accelerated Research: Reducing processing times from hours to minutes.
2. Improved Scalability: Enabling researchers to handle larger datasets and more complex analyses.
3. Reduced Costs: Optimizing resource utilization and minimizing infrastructure expenses.
4. Enhanced Collaboration: Fostering collaboration between academic institutions and industry partners.

The Future of Genomics: Cloud-Powered Innovation

The success of this collaboration underscores the transformative potential of cloud computing in genomics. By providing researchers with access to powerful, scalable, and cost-effective computing resources, cloud-based GPUs are accelerating the pace of discovery and unlocking new possibilities for understanding and treating disease. As the cost of sequencing continues to decline and the volume of genomic data continues to grow, cloud computing will play an increasingly vital role in driving innovation in this critical field. The keywords for this article are: cloud GPUs,genome analysis,high-performance computing,and genomics.

Unlocking Genomic Potential with Cloud Computing

The field of genomics is undergoing a significant transformation, fueled by the increasing availability of powerful and cost-effective computing resources. Riga Technical University (RTU) is at the forefront of this revolution, utilizing Gcore’s cloud-based Graphics Processing Units (GPUs) to dramatically accelerate genome research and analysis.

this innovative approach is not merely about speed; it’s about enabling analysis on a national scale. As E. Liepa from RTU emphasizes:

It is indeed not just about higher speeds. It is important to provide analysis at national scale. Artificial intelligence models already exist but without proper computing power they are and remain only at the theory level.
E. Liepa, Riga Technical University

Liepa’s statement highlights a crucial point: the potential of artificial intelligence in genomics is limited by the availability of adequate computing power. Cloud-based GPUs are bridging this gap, allowing researchers to translate theoretical models into practical applications.

Key Advantages of Cloud-Based GPU Processing

RTU’s adoption of Gcore’s cloud computing infrastructure has yielded several key benefits:

• Accelerated processing: Variant determination is now up to 50 times faster, significantly reducing research timelines.
• Cost-Effective Solution: On-demand access to GPUs eliminates the need for substantial upfront hardware investments, optimizing computing costs. According to a recent report by Grand view Research, the global cloud computing market is projected to reach $1.6 trillion by 2030, driven by the increasing demand for cost-effective and scalable computing solutions.
• Scalable Infrastructure: Resources can be flexibly adjusted based on real-time needs, ensuring optimal performance and resource utilization.
• Data Sovereignty and security: All data processing and storage occur within the European union, ensuring compliance with stringent data protection regulations.

RTU’s Vision for the Future of Genomics

Building on the success of its initial cloud-based GPU implementation, RTU HPC is planning to expand its use of artificial intelligence in genomic research and analysis. This includes:

• Expanded Use of Cloud GPUs: Exploring the application of cloud computing GPU resources in other research domains.
• Continued Collaboration with gcore: Optimizing GPU performance and exploring the use of gcore’s Everywhere Inference solutions for genomic calculations.
• Global Impact: contributing to the “1+ million genome” project, an EU-wide initiative aimed at improving diagnostics and treatment through increased access to genomic data. This project aligns with broader international efforts to promote collaborative research and data sharing in the field of genomics.

The Broader Implications for Personalized Medicine

RTU’s work exemplifies the transformative potential of cloud computing in genomics. by accelerating data processing, reducing costs, and ensuring data security, cloud-based GPUs are empowering researchers to unlock new insights into the human genome. This, in turn, is paving the way for personalized medicine, where treatments are tailored to an individual’s unique genetic makeup. As genomic research continues to advance, we can expect to see even more innovative applications of cloud computing, driving progress in disease diagnosis, prevention, and treatment.

Navigating Global Tech Restrictions: A New Era for Latvian Genomics

Latvia is strategically positioning itself as a leader in biotechnology innovation by leveraging artificial intelligence (AI) in genomics research. This initiative is significantly bolstered by a partnership with Gcore, a global provider of edge and AI cloud services, enabling the country to overcome challenges posed by recent US technology export restrictions.

The US AI Diffusion Rule classifies Latvia as a TIER 2 country, imposing substantial limitations on the import of high-performance computing equipment, particularly GPU servers. This presented a significant hurdle for Latvian institutions seeking to advance AI projects. However, Gcore’s provision of GPUs as a service has effectively circumvented these restrictions, granting Latvian companies and the RTU HPC Center immediate and legal access to the necessary computing power.

“Speed, flexibility, and independence – this is the future of artificial intelligence in healthcare,”

Edgar Liepa, Scientific Assistant, BMC

This access is crucial for maintaining international competitiveness and ensuring the uninterrupted progress of ongoing AI initiatives within the country.

AI and Genomics: A Competitive Edge for Nations

The convergence of AI and genomics is rapidly transforming the life science industry. The ability to harness state-of-the-art graphics processors,leverage local data relevance,and ensure flexible scalability is becoming a critical competitive advantage,not just for businesses,but for entire nations. According to a recent report by McKinsey, AI could contribute up to $1 trillion annually to the healthcare and life sciences sectors globally.

Latvia’s proactive approach,facilitated by Gcore’s infrastructure,demonstrates how countries can establish leadership in biotechnology innovation while maintaining digital independence. This is particularly relevant in an era of increasing geopolitical tensions and technological protectionism.

Gcore’s Commitment to Baltic Innovation

Vsevolod Vayner, Product Director of Edge & AI Cloud at Gcore, expressed pride in supporting Latvia’s vision for AI-driven genomics. He emphasized that this project exemplifies how countries can achieve leadership in biotechnology innovation without sacrificing their digital sovereignty.

“This project serves as an example that countries can be leadership in biotechnology innovation without losing their digital independence.”

Vsevolod Vayner, Product Director of Edge & AI Cloud, Gcore

Strategic Partnerships: The Key to Accessible Computing

Gcore is further strengthening its commitment to the Baltic region through strategic partnerships. Dainis Lukashevich highlighted the recent collaboration with Capital Latvia as a crucial step in implementing their regional strategy. By combining Gcore’s technological capabilities with the expertise of strong local partners, they aim to provide Baltic companies and scientific institutions with innovative, secure, and, most importantly, accessible computing solutions that meet stringent cybersecurity requirements.